Literature DB >> 28656959

Do we need to distinguish exosomes from microvesicles in hematological malignancies?

A Caivano1, L Del Vecchio2,3, P Musto4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28656959     DOI： 10.1038/leu.2017.205

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.

Authors:  Luciana De Luca; Giovanni D'Arena; Vittorio Simeon; Stefania Trino; Ilaria Laurenzana; Antonella Caivano; Francesco La Rocca; Oreste Villani; Giovanna Mansueto; Silvia Deaglio; Idanna Innocenti; Luca Laurenti; Stefano Molica; Giuseppe Pietrantuono; Angelo De Stradis; Luigi Del Vecchio; Pellegrino Musto
Journal:  Leuk Lymphoma       Date:  2016-10-14

Review 2.  The emerging roles of tumor-derived exosomes in hematological malignancies.

Authors:  M Boyiadzis; T L Whiteside
Journal:  Leukemia       Date:  2017-03-21       Impact factor: 11.528

3.  MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.

Authors:  Antonella Caivano; Francesco La Rocca; Vittorio Simeon; Marco Girasole; Simone Dinarelli; Ilaria Laurenzana; Angelo De Stradis; Luciana De Luca; Stefania Trino; Antonio Traficante; Giovanni D'Arena; Giovanna Mansueto; Oreste Villani; Giuseppe Pietrantuono; Luca Laurenti; Luigi Del Vecchio; Pellegrino Musto
Journal:  Cell Oncol (Dordr)       Date:  2016-10-19       Impact factor: 6.730

4.  Expression Profiling of Circulating Microvesicles Reveals Intercellular Transmission of Oncogenic Pathways.

Authors:  Gloria Milani; Tobia Lana; Silvia Bresolin; Sanja Aveic; Anna Pastò; Chiara Frasson; Geertruy Te Kronnie
Journal:  Mol Cancer Res       Date:  2017-02-15       Impact factor: 5.852

5.  High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

Authors:  Antonella Caivano; Ilaria Laurenzana; Luciana De Luca; Francesco La Rocca; Vittorio Simeon; Stefania Trino; Fiorella D'Auria; Antonio Traficante; Maddalena Maietti; Tiziana Izzo; Giovanni D'Arena; Giovanna Mansueto; Giuseppe Pietrantuono; Luca Laurenti; Pellegrino Musto; Luigi Del Vecchio
Journal:  Tumour Biol       Date:  2015-07-09

6.  Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.

Authors:  J Boysen; M Nelson; G Magzoub; G P Maiti; S Sinha; M Goswami; S K Vesely; T D Shanafelt; N E Kay; A K Ghosh
Journal:  Leukemia       Date:  2016-08-02       Impact factor: 11.528

7.  Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche.

Authors:  Antonella Chillemi; Valeria Quarona; Luca Antonioli; Davide Ferrari; Alberto L Horenstein; Fabio Malavasi
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

8.  MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.

Authors:  Luciana De Luca; Stefania Trino; Ilaria Laurenzana; Vittorio Simeon; Giovanni Calice; Stefania Raimondo; Marina Podestà; Michele Santodirocco; Lazzaro Di Mauro; Francesco La Rocca; Antonella Caivano; Annalisa Morano; Francesco Frassoni; Daniela Cilloni; Luigi Del Vecchio; Pellegrino Musto
Journal:  Oncotarget       Date:  2016-02-09
  8 in total
  7 in total

1.  Rational biomarker development for the early and minimally invasive monitoring of AML.

Authors:  Sherif Abdelhamed; John T Butler; Seul Jung; Ding-Wen Chen; Gaye Jenkins; Lina Gao; Jeong Y Lim; Jeffery M Klco; Terzah M Horton; Peter Kurre
Journal:  Blood Adv       Date:  2021-11-09

Review 2.  Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.

Authors:  Kerui Wu; Fei Xing; Shih-Ying Wu; Kounosuke Watabe
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-10-18       Impact factor: 10.680

Review 3.  Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Authors:  Alessandra Tuccitto; Eriomina Shahaj; Elisabetta Vergani; Simona Ferro; Veronica Huber; Monica Rodolfo; Chiara Castelli; Licia Rivoltini; Viviana Vallacchi
Journal:  Virchows Arch       Date:  2018-10-29       Impact factor: 4.064

4.  Analysis of Amount, Size, Protein Phenotype and Molecular Content of Circulating Extracellular Vesicles Identifies New Biomarkers in Multiple Myeloma.

Authors:  Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Antonella Caivano; Daniela Lamorte; Marco Girasole; Simone Dinarelli; Angelo De Stradis; Vitina Grieco; Maddalena Maietti; Antonio Traficante; Teodora Statuto; Oreste Villani; Pellegrino Musto; Alessandro Sgambato
Journal:  Int J Nanomedicine       Date:  2021-05-07

5.  Response commentary: exosomes vs microvesicles in hematological malignancies.

Authors:  T L Whiteside; M Boyiadzis
Journal:  Leukemia       Date:  2017-08-04       Impact factor: 11.528

Review 6.  Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies.

Authors:  Ilaria Laurenzana; Daniela Lamorte; Stefania Trino; Luciana De Luca; Concetta Ambrosino; Pietro Zoppoli; Vitalba Ruggieri; Luigi Del Vecchio; Pellegrino Musto; Antonella Caivano; Geppino Falco
Journal:  Stem Cells Int       Date:  2018-05-27       Impact factor: 5.443

7.  Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton.

Authors:  Annalisa Adamo; Jessica Brandi; Simone Caligola; Pietro Delfino; Riccardo Bazzoni; Roberta Carusone; Daniela Cecconi; Rosalba Giugno; Marcello Manfredi; Elisa Robotti; Emilio Marengo; Giulio Bassi; Paul Takam Kamga; Giada Dal Collo; Alessandro Gatti; Angela Mercuri; Maddalena Arigoni; Martina Olivero; Raffaele A Calogero; Mauro Krampera
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.